Gh Research Ordinary Shares
(GHRS)
|
7.9 |
$216M |
|
9.3M |
23.33 |
Kymera Therapeutics
(KYMR)
|
7.3 |
$202M |
|
3.2M |
63.49 |
Arcus Biosciences Incorporated
(RCUS)
|
5.0 |
$138M |
|
3.4M |
40.47 |
Merus N V
(MRUS)
|
4.8 |
$132M |
|
4.1M |
31.80 |
Protagonist Therapeutics
(PTGX)
|
4.5 |
$125M |
|
3.7M |
34.20 |
Xenon Pharmaceuticals
(XENE)
|
3.7 |
$103M |
|
3.3M |
31.24 |
Repare Therapeutics Ord
(RPTX)
|
3.7 |
$103M |
|
4.9M |
21.09 |
Relay Therapeutics
(RLAY)
|
3.5 |
$96M |
|
3.1M |
30.71 |
Crinetics Pharmaceuticals In
(CRNX)
|
3.1 |
$85M |
|
3.0M |
28.41 |
Cullinan Oncology
(CGEM)
|
3.0 |
$83M |
|
5.4M |
15.43 |
Argenx Se Sponsored Adr
(ARGX)
|
2.7 |
$76M |
|
216k |
350.19 |
Xoma Corp Del Com New
(XOMA)
|
2.7 |
$74M |
|
3.5M |
20.85 |
Olema Pharmaceuticals
(OLMA)
|
2.5 |
$69M |
|
7.4M |
9.36 |
Galapagos Nv Spon Adr
(GLPG)
|
2.3 |
$64M |
|
1.2M |
55.13 |
Lexicon Pharmaceuticals Com New
(LXRX)
|
2.1 |
$57M |
|
14M |
3.94 |
Amarin Corp Spons Adr New
(AMRN)
|
2.0 |
$56M |
|
17M |
3.37 |
Eqrx
|
1.9 |
$54M |
|
7.9M |
6.82 |
Syndax Pharmaceuticals
(SNDX)
|
1.7 |
$46M |
|
2.1M |
21.89 |
Revolution Medicines
(RVMD)
|
1.7 |
$46M |
|
1.8M |
25.17 |
4d Molecular Therapeutics In
(FDMT)
|
1.6 |
$44M |
|
2.0M |
21.94 |
Essa Pharma Com New
(EPIX)
|
1.5 |
$41M |
|
2.9M |
14.20 |
Rain Therapeutics
|
1.4 |
$38M |
|
3.0M |
12.88 |
Miragen Therapeutics
(VRDN)
|
1.3 |
$37M |
|
1.9M |
19.77 |
Relmada Therapeutics
(RLMD)
|
1.3 |
$37M |
|
1.6M |
22.53 |
Verastem
|
1.3 |
$35M |
|
17M |
2.05 |
Ac Immune Sa SHS
(ACIU)
|
1.3 |
$35M |
|
7.1M |
4.95 |
Chinook Therapeutics
|
1.1 |
$29M |
|
1.8M |
16.31 |
Kura Oncology
(KURA)
|
1.0 |
$29M |
|
2.1M |
14.00 |
Tyra Biosciences
(TYRA)
|
1.0 |
$26M |
|
1.9M |
14.07 |
Spero Therapeutics
(SPRO)
|
0.9 |
$25M |
|
1.6M |
16.01 |
Cytomx Therapeutics
(CTMX)
|
0.9 |
$25M |
|
5.8M |
4.33 |
Replimune Group
(REPL)
|
0.9 |
$25M |
|
927k |
27.10 |
Aclaris Therapeutics
(ACRS)
|
0.9 |
$25M |
|
1.7M |
14.54 |
Ikena Oncology
(IKNA)
|
0.8 |
$23M |
|
1.8M |
12.54 |
Cti Biopharma
|
0.8 |
$22M |
|
8.9M |
2.48 |
Alpine Immune Sciences
(ALPN)
|
0.8 |
$22M |
|
1.6M |
13.85 |
Aadi Bioscience
(AADI)
|
0.8 |
$22M |
|
899k |
24.15 |
Ovid Therapeutics
(OVID)
|
0.8 |
$21M |
|
6.6M |
3.21 |
Pieris Pharmaceuticals
(PIRS)
|
0.7 |
$20M |
|
5.3M |
3.78 |
Janux Therapeutics
(JANX)
|
0.7 |
$20M |
|
1.0M |
19.73 |
Pyxis Oncology Common Stock
(PYXS)
|
0.7 |
$20M |
|
1.8M |
10.97 |
Calliditas Therapeutics Ab Sponsered Ads
(CALT)
|
0.7 |
$19M |
|
750k |
24.76 |
Ngm Biopharmaceuticals
(NGM)
|
0.6 |
$17M |
|
955k |
17.71 |
Point Biopharma Global
|
0.6 |
$16M |
|
2.9M |
5.60 |
Silence Therapeutics Ads
(SLN)
|
0.6 |
$16M |
|
667k |
23.40 |
Infinity Pharmaceuticals
(INFIQ)
|
0.5 |
$14M |
|
6.4M |
2.25 |
Sutro Biopharma
(STRO)
|
0.5 |
$14M |
|
925k |
14.88 |
Glycomimetics
(GLYC)
|
0.5 |
$14M |
|
9.5M |
1.44 |
Day One Biopharmaceuticals I
(DAWN)
|
0.5 |
$14M |
|
809k |
16.85 |
Cogent Biosciences
(COGT)
|
0.5 |
$13M |
|
1.5M |
8.58 |
Viracta Therapeutics
(VIRX)
|
0.5 |
$13M |
|
3.4M |
3.65 |
Molecular Templates
|
0.4 |
$12M |
|
3.1M |
3.92 |
Contrafect Corp Com New
|
0.4 |
$10M |
|
4.0M |
2.63 |
Elevation Oncology
(ELEV)
|
0.4 |
$9.7M |
|
1.6M |
6.02 |
Mei Pharma Com New
|
0.3 |
$9.4M |
|
3.5M |
2.67 |
Cidara Therapeutics Inc Common Stock Usd 0.0001
(CDTX)
|
0.3 |
$8.7M |
|
6.9M |
1.27 |
Molecular Partners Ads
(MOLN)
|
0.3 |
$8.5M |
|
443k |
19.29 |
Nuvalent Inc-a
(NUVL)
|
0.3 |
$8.5M |
|
449k |
19.04 |
Inventiva Sa Ads
(IVA)
|
0.3 |
$7.4M |
|
545k |
13.66 |
Concert Pharmaceuticals I equity
|
0.3 |
$7.1M |
|
2.3M |
3.15 |
Mirum Pharmaceuticals
(MIRM)
|
0.3 |
$7.0M |
|
436k |
15.95 |
Eledon Pharmaceuticals
(ELDN)
|
0.2 |
$6.1M |
|
1.4M |
4.41 |
Selecta Biosciences
(RNAC)
|
0.2 |
$5.6M |
|
1.7M |
3.26 |
Centessa Pharmaceuticals Sponsored Ads
(CNTA)
|
0.2 |
$5.1M |
|
455k |
11.26 |
Eucrates Biomedical Acqu Cor Unit 10/23/2027
|
0.2 |
$5.0M |
|
500k |
9.98 |
Calithera Biosciences
|
0.2 |
$5.0M |
|
7.5M |
0.67 |
Frazier Lifesciences Acqu Unit 12/09/2025
|
0.2 |
$5.0M |
|
500k |
9.90 |
5 01 Acquisition Corp Com Cl A
|
0.2 |
$4.9M |
|
500k |
9.85 |
Research Alliance Corp Ii Com Cl A
|
0.2 |
$4.9M |
|
500k |
9.72 |
Genocea Biosciences Com New
(GNCAQ)
|
0.2 |
$4.7M |
|
4.0M |
1.16 |
Corvus Pharmaceuticals
(CRVS)
|
0.1 |
$3.3M |
|
1.4M |
2.41 |
Galmed Pharmaceuticals SHS
|
0.1 |
$3.3M |
|
1.8M |
1.82 |
Angion Biomedica Corp
|
0.1 |
$3.1M |
|
1.1M |
2.90 |
Erytech Pharma Sponsored Adr
|
0.1 |
$3.1M |
|
1.3M |
2.36 |
Aileron Therapeutics
|
0.1 |
$3.0M |
|
5.3M |
0.56 |
Jiya Acquisition Corp Com Cl A
|
0.1 |
$2.9M |
|
300k |
9.77 |
Forward Pharma A/s Sponsord Ads New
|
0.1 |
$2.6M |
|
433k |
5.97 |
Acumen Pharmaceuticals
(ABOS)
|
0.1 |
$2.0M |
|
290k |
6.76 |
X4 Pharmaceuticals
(XFOR)
|
0.1 |
$1.9M |
|
848k |
2.29 |
Generation Bio
(GBIO)
|
0.0 |
$1.3M |
|
189k |
7.08 |
Bionomics Ads
(BNOX)
|
0.0 |
$1.0M |
|
81k |
12.55 |
Rezolute Com New
(RZLT)
|
0.0 |
$912k |
|
191k |
4.78 |
Voyager Therapeutics
(VYGR)
|
0.0 |
$60k |
|
22k |
2.70 |